What company are you calling from? <a href=" http://israelstartupnetwork.com/topamax-drug-classification.pptx ">does 25 mg topamax look like</a> Two-way transparency is crucial to address this risk, &ldquo;since it allows critical review of any secondary analysis by the public and the EMA&rdquo;, they add. Moreover, there must be strong safeguards in place &ldquo;to ensure that the clinical investments and intellectual property of innovators are not jeopardised by &lsquo;free riders&rsquo;&rdquo;.